Lisanti Capital Growth, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$7,025,312
+48.2%
78,425
+36.9%
1.11%
+67.9%
Q1 2023$4,739,506
-38.2%
57,275
-41.3%
0.66%
-36.9%
Q4 2022$7,669,948
+13.9%
97,520
+82.7%
1.05%
-52.3%
Q3 2019$6,734,000
+43.9%
53,385
+14.2%
2.20%
+16.2%
Q4 2018$4,679,000
+69.3%
46,765
+93.9%
1.89%
+96.9%
Q3 2018$2,764,00024,1200.96%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders